Valor202020212022202320242025TTMGastos comerciales, generales y administrativos1.55 B1.73 B1.87 B1.64 B1.77 B1.97 B1.97 BInvestigación y desarrollo———————Beneficio operativo1.97 B2.38 B1.43 B1.26 B1.35 B1.56 B1.56 BTotal de ingresos no operativos-87 M218 M-193 M-132 M-171 M-238 M-238 MGastos por intereses, netos de intereses capitalizados166 M152 M148 M163 M227 M279 M277 MIngresos no operativos, una vez deducidos los gastos por intereses-329 M-303 M-286 M-315 M-428 M-543 M-541 MIngresos/gastos extraordinarios76 M369 M-55 M20 M30 M26 M26 MBeneficio antes de impuestos1.96 B2.68 B1.28 B1.16 B1.19 B1.36 B1.36 BParticipación en los beneficios75 M78 M44 M26 M19 M42 M42 MImpuestos460 M597 M264 M248 M273 M314 M314 MParticipación minoritaria68 M85 M69 M54 M50 M54 M54 MOtros ingresos/gastos después de impuestos81 M63 M-66 M-41 M-15 M-24 M-24 MBeneficio neto antes de actividades interrumpidas1.43 B2 B946 M854 M871 M992 M992 MOperaciones suspendidas00—————Beneficio neto1.43 B2 B946 M854 M871 M992 M992 MAjuste por dilución———————Dividendos de las acciones preferentes———————Beneficio neto diluido atribuible a los accionistas1.43 B1.99 B942 M850 M866 M988 M988 MBeneficio básico por acción10.6215.858.17.597.788.878.87Beneficio por acción diluido10.4715.557.977.497.698.758.75Número medio de acciones ordinarias134 M125 M116 M112 M111 M111 M446 MAcciones diluidas136 M128 M118 M113 M113 M113 M452 MEBITDA2.17 B2.64 B1.73 B1.55 B1.41 B1.58 B1.58 BEBIT1.81 B2.23 B1.29 B1.11 B919 M1.01 B1.01 BCosto de los ingresos5.8 B6.58 B6.45 B6.2 B6.63 B7.37 B7.37 BOtros costes de producción———————Amortización y depreciación (flujo de caja)361 M408 M437 M439 M493 M570 M570 M
Quest Diagnostics Incorporated
Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
As of 2020, the company had approximately 48,000 employees, and it generated more than $7.7 billion in revenue in 2019. The company offers access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders, COVID-19, and employment and court-ordered drug testing.